高血压患者基线血浆锌与首次卒中风险的巢式病例对照研究
本研究基于CSPPT试验,采用巢式病例对照设计,纳入599例首次卒中病例和599例匹配对照,探讨高血压患者基线血浆锌与首次卒中风险的关系。结果显示,基线血浆锌≥106.9 μg/dL者首次出血性卒中风险显著低于<106.9 μg/dL者(多因素校正OR 0.45,95%CI 0.21-0.94),但血浆锌与首次缺血性卒中无显著关联(OR 1.16,95%CI 0.83-1.61)。
要点
- 高血压患者基线血浆锌≥106.9 μg/dL与首次出血性卒中风险降低相关。
- 血浆锌与首次缺血性卒中无显著关联。
- BMI≥25.0 kg/m2或血浆铜<100.1 μg/dL者中,锌与出血性卒中的负关联更强。
核心结论
- 在高血压患者样本中,基线血浆锌与首次出血性卒中呈显著负关联,与首次缺血性卒中无显著关联。
研究设计与样本
- 研究人群取自CSPPT(中国卒中一级预防试验),采用巢式病例对照设计,包括599例首次卒中病例和599例匹配对照。
主要发现
- 与基线血浆锌<106.9 μg/dL(中位数)者相比,血浆锌≥106.9 μg/dL者首次出血性卒中风险显著降低(多因素校正OR 0.45;95%CI 0.21-0.94)。
- 血浆锌与首次出血性卒中的负关联在BMI≥25.0 kg/m2或基线血浆铜<100.1 μg/dL者中显著更强(两者交互作用P<0.05)。
- 血浆锌与首次缺血性卒中无显著关联(<103.3 vs ≥103.3 μg/dL[中位数];多因素校正OR 1.16;95%CI 0.83-1.61)。
关键数值与推荐
- 基线血浆锌中位数106.9 μg/dL用于出血性卒中分析,103.3 μg/dL用于缺血性卒中分析。
- 血浆铜阈值100.1 μg/dL,BMI阈值25.0 kg/m2,交互作用P<0.05。
临床怎么用
- 在高血压患者中,可关注基线血浆锌水平以评估首次出血性卒中风险,但需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- We aimed to examine the relation of baseline plasma zinc with the risk of first stroke and investigate any possible effect modifiers in hypertensive patients. Methods- The study population was drawn from the CSPPT (China Stroke Primary Prevention Trial), using a nested case-control design, including 599 first stroke cases and 599 matched controls. Results- Compared with participants with baseline plasma zinc <106.9 μg/dL (median), a significantly lower risk of first hemorrhagic stroke was found in those with plasma zinc ≥106.9 μg/dL (multivariate-adjusted odds ratio, 0.45; 95% CI, 0.21-0.94). Furthermore, the inverse plasma zinc-first hemorrhagic stroke association was significantly stronger in participants with body mass index ≥25.0 kg/m2 or plasma copper <100.1 μg/dL at baseline (Pinteraction <0.05 for both variables). However, there was no significant association between plasma zinc and first ischemic stroke (<103.3 versus ≥103.3 μg/dL [median]; multivariate-adjusted odds ratio, 1.16; 95% CI, 0.83-1.61). Conclusions- In this sample of hypertensive patients, we found a significant, inverse association between plasma zinc and first hemorrhagic stroke. Clinical Trial Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT00794885.
引用
- Zhang J, Cao J, Zhang Y, et al. Baseline Plasma Zinc and Risk of First Stroke in Hypertensive Patients: A Nested Case-Control Study. Stroke. 2019. PMID: 31446884. doi:10.1161/STROKEAHA.119.027003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。